This post was written by Paul Sheives.

Under Executive Order 13563, ‘‘Improving Regulation and Regulatory Review,’’ FDA is reviewing the effectiveness of the Agency’s regulations in light of public health needs and advances in innovation. To this end, FDA requests public comment and supporting data on which of its existing rules are outmoded, ineffective, insufficient, or excessively burdensome and thus may be good candidates to be modified, streamlined, expanded, or repealed. The Agency is also interested in suggestions for approaches to prioritizing review of these regulations. FDA is accepting written comments until June 27, 2011.